AMBISOME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ambisome, and what generic alternatives are available?
Ambisome is a drug marketed by Astellas and is included in one NDA.
The generic ingredient in AMBISOME is amphotericin b. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the amphotericin b profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ambisome
A generic version of AMBISOME was approved as amphotericin b by XGEN PHARMS on April 29th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMBISOME?
- What are the global sales for AMBISOME?
- What is Average Wholesale Price for AMBISOME?
Summary for AMBISOME
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 62 |
Clinical Trials: | 59 |
Patent Applications: | 3,817 |
Drug Prices: | Drug price information for AMBISOME |
What excipients (inactive ingredients) are in AMBISOME? | AMBISOME excipients list |
DailyMed Link: | AMBISOME at DailyMed |
US Patents and Regulatory Information for AMBISOME
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | AMBISOME | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 050740-001 | Aug 11, 1997 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AMBISOME
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Astellas | AMBISOME | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 050740-001 | Aug 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Astellas | AMBISOME | amphotericin b | INJECTABLE, LIPOSOMAL;INJECTION | 050740-001 | Aug 11, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AMBISOME
See the table below for patents covering AMBISOME around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Hong Kong | 115393 | ⤷ Sign Up | |
Ireland | 872148 | ⤷ Sign Up | |
Ireland | 62110 | Improved amphotericin B liposome preparation | ⤷ Sign Up |
Japan | H01160915 | IMPROVED METHOD FOR PREPARATION OF AMPHOTERICIN B | ⤷ Sign Up |
European Patent Office | 0260811 | ⤷ Sign Up | |
Australia | 598958 | ⤷ Sign Up | |
Denmark | 175052 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |